Press Releases Healios K.K.

Equities

4593

JP3835100003

Delayed Japan Exchange Other stock markets 10:27:34 2024-07-15 pm EDT			5-day change	1st Jan Change
183 ^JPY	0.00%		+7.02%	+10.91%

Jun. 20	Healios to Book $3 Million Upfront Payment as Sales Revenue in Q2 Following License Deal with Astellas Institute	MT
Jun. 19	Healios K.K. Enters into License Agreement with Astellas Institute for Regenerative Medicine	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Healios K K : TREASURE study results to be presented at the 14th World Stroke Congress	22-08-10	PU
Healios eNK Cells: Regenerative Medicine Product Quality Consultation with the PMDA for Planned Clinical Trials	22-07-12	PU
Healios K K : Exercise of Exclusive Option for a License Agreement with STEMAXON for the Development of UDC-Derived Photoreceptor Cells	22-07-12	PU
Healios’ eNK Cells: Joint Research with Hyogo Medical University for Mesothelioma	22-06-02	PU
Healios K K : Business Briefing for Institutional Investors	22-04-05	PU
Healios K K : Progress Update in Relation to Application for Approval for HLCM051 for ARDS	22-04-04	PU
Healios K K : Completion of 365 Days Post-Administration Follow Up for TREASURE Study for Patients with Ischemic Stroke	22-04-04	PU
Healios K K : Joint Research with the Division of Regenerative Medicine, the Institute of Medical Science for Developing a Mass Production Method of UDC Liver Buds	22-04-01	PU
Healios K K : License Agreement with CellFiber Co., Ltd.	22-03-24	PU
Healios K K : Notice Concerning Reduction of Capital Stock and Capital Reserves and Appropriation of Surplus	22-02-24	PU
Healios K K : Notice of the Partial Amendments to Articles of Incorporation	22-02-24	PU
Healios K K : Notice of the Nomination of Candidates for the HEALIOS K.K. Board of Directors	22-02-24	PU
Healios K K : Announcement of Change in Management	22-01-31	PU
Healios K K : ’ Gene-Edited NK Cells：Joint Research with Hiroshima University for Hepatocellular Carcinoma	21-12-20	PU
Healios K K : Data from Athersys’ clinical trial evaluating MultiStem cell therapy for ARDS published in Intensive Care Medicine	21-12-01	PU
FY2021 Q3 Financial Results	21-11-12	PU
The anti-tumor effect of Healios' gene edited iPSC-derived NK cells in a lung cancer cell line	21-11-07	PU
Healios K K : Announcement of Determination of the Issue Price and Other Matters for the Issuance of New Shares through an International Offering	21-09-15	PU
Healios K K : Announcement of Issuance of New Shares through an International Offering	21-09-15	PU
Healios K K : Successful differentiation of Healios UDCs into pancreatic β-cells in our joint research with the National Center for Global Health and Medicine	21-09-02	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Healios K.K.

Equities

4593

JP3835100003

Press Releases

Filters